Markets

Insider Trading

Hedge Funds

Retirement

Opinion

16 Most Advanced Countries in Medicine

In this article, we list and discuss the 16 Most Advanced Countries in Medicine. If you would like to skip our detailed discussion of the medicine and pharmaceutical industry, you can go directly to 5 Most Advanced Countries in Medicine.

Despite the tragedy of the Pandemic, Covid-19 did successfully revolutionize the medical world. According to the National Library of Medicine, the US government invested at least $31.9 billion in researching, developing, and purchasing mRNA COVID-19 vaccines.

So while the Global Pandemic caused most industries to crash, the pharmaceutical market was one of the obvious exceptions. In fact, it surged the highest during COVID-19. Pfizer Inc (NYSE: PFE), crossed the $100 billion mark in annual revenue. The surge in revenue was due to the massive haul from its COVID-19 products. Its BioNTech-partnered vaccine, Comirnaty, earned $37.8 billion, while its oral antiviral Paxlovid fetched another $18.9 billion in 2022.

Other companies like Cigna Corporation (NYSE: CI), Sanofi (NASDAQ: SNY), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), and Amgen Inc. (NASDAQ: AMGN) also gained substantial growth during the pandemic period, and their stocks remain the top choice for investors in 2024 as well (See: 13 Best Medical Stocks To Invest In).   

Industry Outlook 

Due to its ever-increasing demand, the medicine market has experienced exponential growth over time. In 2001, the pharmaceutical industry was valued at $390 billion, which then grew by 320% in the next (nearly) two decades. In 2019, the industry stood at a valuation of $1.25 trillion, as researched by the National Library of Medicine

After 2019, when the pandemic took the world by surprise, the medicine industry further experienced substantial growth as countries increased their vaccine expenditure. A report by the OECD says that the pharmaceutical industry invested $129 billion in research and development (R&D) in 2021 alone, of which the majority expense was by the US. However, the average OECD health expenditure to GDP ratio declined from the peak of 9.7% that was during the pandemic in 2021 to 9.2% in 2022. 

While further going into depth of the country-level data, countries that spent the most on health in 2022 were the US, Germany, and France, spending 16.6%, 12.7%, and 12.1% of their total GDPs, respectively. 

As far as number of pharmacists go, according to the 2021 OECD report, Japan is the top country with the most practicing pharmacists, with 199 pharmacists per 1000 population. Following Japan — Belgium, and Italy have the most pharmacists — 131 and 128 per 1000 people respectively. 

All in all, the medical world changed drastically post-COVID, and in the next six to seven years, by 2030, new trends and challenges will shape the pharmaceutical industry. For instance, artificial intelligence (AI) will play a crucial role in R&D and will be widely used by companies in various areas of medicine. 

In fact, this aspect of innovation has already started to take shape — Nana Kofi Quakyi, a program manager at the Aurum Institute in Ghana, is currently working to develop an AI model to help healthcare workers prescribe antibiotics without triggering antimicrobial resistance. In his End of Year report, Bill Gates, the former CEO of Microsoft, highlighted Nana’s work and prominent use cases of AI in the medicinal world. Gates Foundation is now looking at how AI tools can address major health issues like AIDs, TB, and Malaria. The National Library of Medicine has further endorsed this development, reporting that AI has emerged successfully as a powerful tool in the medical sector. 

Key players in the pharmaceutical industry, such as Sanofi SA (NASDAQ: SNY), Pfizer Inc (NYSE: PFE), and Janssen Biotech, which is owned by Johnson & Johnson (NYSE: JNJ), have invested in AI to use it for drug discovery and other purposes. 

In 2018, Sanofi SA (NASDAQ: SNY) partnered with Aily Labs and developed an AI platform called “plai.” The app essentially aggregates the company’s internal data and provides an unprecedented 360° view across all its activities. On the other hand, Pfizer Inc (NYSE: PFE), which is currently ranked at the top in the pharma world, used IBM’s supercomputing and AI since 2020 and developed new drugs like PAXLOVID, an oral COVID-19 treatment approved in 2022. Entering 2024, both Sanofi SA (NASDAQ: SNY) and Pfizer Inc (NYSE: PFE) aim to integrate more AI within their operations.

Let’s now move to the list of the top countries in medicine.

16 Most Advanced Countries in Medicine

Our Methodology 

For our list of the most advanced nations in medicine, we’ve ranked them based on three reports. These are the following – Legatum Prosperity Index, 2023, Countries’ Citations in Clinical Medicine, by Institute of Scientific Information, and other credible sources on the internet

Legatum Prosperity Index’s health ‘pillar’ measures the extent to which people have access to essential and advanced healthcare services. The Institute of Scientific Information report, on the other hand, is about the number of citations per paper for countries in the field of clinical medicine. 

Lastly, the CEO-World report is based on a statistical analysis that accounted for factors such as healthcare infrastructure, government readiness, healthcare professionals, and quality of medicine among others. 

We’ve scored these three indexes and then averaged out the scores for the top countries in the three reports. We haven’t considered the countries that did not appear in more than one report. The data for healthcare spending and physicians per 1,000 people in our listed countries comes from the World Bank. The list is presented in ascending order of high scores.

16 Most Advanced Countries in Medicine

16. France

Citations per paper: 8.64

Healthcare Index: 48.27

Legatum-Prosperity Health Score: 80.46

Average: 4.33

Ranked number sixteen, France is known for its rich medical history, having paved the way for modern-day surgeries and chemotherapy. Not only is France recognized for its medical research but also for its healthcare system, which provides universal coverage for residents. In 2023, France spent around 12.1% of its GDP on healthcare which is 1.9% higher than the OECD average. France had 3.2 practicing doctors and 9.7 practicing nurses per 1000 population in 2023. 

15. Austria

Citations per paper: 8.34

Healthcare Index: 54.86

Legatum-Prosperity Health Score: 80.23

Average: 4.33

According to the 2018 Health System Review Report by the Euro Health Observatory, Austria residents have the lowest rate of unmet medical needs in the EU. Apart from healthcare, Austria is also home to several renowned medical schools, including the Vienna School of Medicine. 

There are 5.4 practicing doctors and 10.6 practicing nurses per 1000 people in Austria as of today, according to OECD. The country also has many state-of-the-art hospitals with high-quality equipment like the Vienna General Hospital. Austria is also known to have one of the highest global expenditures on pharmaceuticals and the country spent $7,275 per capita on health in 2023.

14. Belgium

Citations per paper: 11.56

Healthcare Index: 60.16

Legatum-Prosperity Health Score: 80.6

Average: 6.66

Belgium is another medically advanced country, with its medical technology market expected to grow dramatically and reach $4.22 billion in 2024. The country has some of the EU’s best medical universities, like KU Leuven and Ghent University. Austria prioritizes medical research, and Austrian researchers have made notable contributions to fields like immunology and cancer research. In fact, Belgium’s history with immunology goes all the way back to 1919, when Jules Bordet received the first Nobel Prize for his work discoveries within the field.

Belgium also collaborates with renowned international organizations like WHO, which further enhances its standing in the medicine industry. In 2023, Belgium spent 10.9% of its GDP on health and had the 7th highest spending on health expenditures in the world.

13. Denmark

Citations per paper: 12.50

Healthcare Index: 48.54

Legatum-Prosperity Health Score: 81.07

Average: 7

Denmark is considered medically advanced due to its robust healthcare system, excellent medical services, and significant focus on preventative care. It is also one of Europe’s leading medical technology countries, along with Norway, Sweden, and Germany. 

Denmark offers patient-centric services which include online systems where healthcare professionals can access a patient’s data. Denmark has 4.4 practicing doctors and 10.2 practicing nurses per 1000 people as of 2023. According to the International Trades Administration, the Danish digital health market will surpass $1 billion by 2025.

12. Germany

Citations per paper: 7.79 

Healthcare Index: 64.66

Legatum-Prosperity Health Score: 81.41

Average: 7.33

Ranked 12th, Germany has a rich history in the field of medicine and is the birthplace of prominent scientists like Paul Ehrlich and Alfred Bertheim — the inventors of arsphenamine. It is also known for pharmaceutical industry giant Bayer AG (ETR: BAYN) and has the largest healthcare market in the EU. 

Moreover, manufacturing medical technology companies like B.Braun help the medical devices industry grow within the country. By 2028, the medical technology market in Germany is projected to grow by 4.39%. Germany’s solid health infrastructure and focus on research have helped with its advancements in the medical field.

11. USA

Citations per paper: 13.50

Healthcare Index: 56.71

Legatum-Prosperity Health Score: 73.26

Average: 7.33

Despite its expensive healthcare system, the US is considered one of the most medically advanced countries with the second most number of citations per paper. The US is a global leader in the medical field and has some of the best medical research institutions like Harvard and Johns Hopkins. It is at the forefront of medical research, especially in areas like medical technology and Cancer research. The US healthcare costs were $4.7 trillion in 2023 and are expected to grow to $7.3 trillion by 2031.

10. Finland

Citations per paper: 12.62

Healthcare Index: 52.1 

Legatum-Prosperity Health Score: 81.19

Average: 8

Finland is a country that has made major strides in the world of medical research, mainly in the genomics field. It is home to FinnGen, a Finnish biobank, and is one of the world’s leading genomics projects. Finland also has an amazing tax-funded healthcare system and Finnish people are reported to have an 88% satisfaction rate. In 2023, Finland spent $5,599 per capita which is equal to 10.0% of the country’s GDP. Finland also has 3.6 practicing doctors and 18.9 practicing nurses per 1000 people. 

9. Australia

Citations per paper: 9.85

Healthcare Index: 74.11

Legatum-Prosperity Health Score: 80.36

Average: 8.66

Standing at number nine, Australia has one of the best healthcare systems in the world with respect to testing facilities, accessibility, medical care, and healthcare facilities. The country focuses on medical research, especially in the infectious diseases and cancer research fields. In fact, Australia is an international leader in the Cancer research domain and has made significant breakthroughs in the cancer prevention and support domains. The Australian pharmaceutical market played a major role in Covid-19 vaccine development and the market is expected to reach $10.16 billion in 2024.

8. Japan

Citations per paper: 7.53

Healthcare Index: 59.52

Legatum-Prosperity Health Score: 86.5

Average: 8.67

Japan is recognized globally for its contributions to the medical research and technology field, with the country’s medical device market projected to reach $94.23 billion by 2032. The country is known for its innovations in regenerative medicine and robotics. In 2023, Japan spent 11.5% of its GDP on health and is on track to advance even further in the field of medicine in the next few years. The future of medicine in Japan holds robot surgeries and telemedicine, which are currently being launched and regulated. 

7. Israel

Citations per paper: 8.14

Healthcare Index: 61.73

Legatum-Prosperity Health Score: 83.1

Average: 9

Israel is also one of the most advanced countries in medicine as of today. The country spends 7.4% of its GDP on health and has an average of 3.4 practicing doctors per 1000 people. Israel is also home to top research universities like the Tel Aviv University and Weizmann Institute. 

6. Switzerland

Citations per paper: 11.51

Healthcare Index: 59.6

Legatum-Prosperity Health Score: 82.11

Average: 9

Ranked number sixth, Switzerland is known for its world-class hospitals, research institutions, and pharmaceutical companies like Novartis International AG (NYSE: NVS). Swedish researchers have also made significant advancements in molecular biology, genetics, and pharmaceutical development within the last decade. The country provides paid private healthcare insurance to its residents. As of 2024, Switzerland spends 11.3% of its GDP on health which is around $8,049 per capita. There are 4.4 practicing doctors and 18.4 practicing nurses per 1000 people in Switzerland. 

Click to continue reading and see the 5 Most Advanced Countries in Medicine.

Suggested articles:

Disclosure: None. 16 Most Advanced Countries in Medicine is originally published on Insider Monkey.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

AI is eating the world—and the machines behind it are ravenous.

Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink.

Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and building the digital future. But there’s one urgent question few are asking:

Where will all of that energy come from?

AI is the most electricity-hungry technology ever invented. Each data center powering large language models like ChatGPT consumes as much energy as a small city. And it’s about to get worse.

Even Sam Altman, the founder of OpenAI, issued a stark warning:

“The future of AI depends on an energy breakthrough.”

Elon Musk was even more blunt:

“AI will run out of electricity by next year.”

As the world chases faster, smarter machines, a hidden crisis is emerging behind the scenes. Power grids are strained. Electricity prices are rising. Utilities are scrambling to expand capacity.

And that’s where the real opportunity lies…

One little-known company—almost entirely overlooked by most AI investors—could be the ultimate backdoor play. It’s not a chipmaker. It’s not a cloud platform. But it might be the most important AI stock in the US owns critical energy infrastructure assets positioned to feed the coming AI energy spike.

As demand from AI data centers explodes, this company is gearing up to profit from the most valuable commodity in the digital age: electricity.

The “Toll Booth” Operator of the AI Energy Boom

  • It owns critical nuclear energy infrastructure assets, positioning it at the heart of America’s next-generation power strategy.
  • It’s one of the only global companies capable of executing large-scale, complex EPC (engineering, procurement, and construction) projects across oil, gas, renewable fuels, and industrial infrastructure.
  • It plays a pivotal role in U.S. LNG exportation—a sector about to explode under President Trump’s renewed “America First” energy doctrine.

Trump has made it clear: Europe and U.S. allies must buy American LNG.

And our company sits in the toll booth—collecting fees on every drop exported.

But that’s not all…

As Trump’s proposed tariffs push American manufacturers to bring their operations back home, this company will be first in line to rebuild, retrofit, and reengineer those facilities.

AI. Energy. Tariffs. Onshoring. This One Company Ties It All Together.

While the world is distracted by flashy AI tickers, a few smart investors are quietly scooping up shares of the one company powering it all from behind the scenes.

AI needs energy. Energy needs infrastructure.

And infrastructure needs a builder with experience, scale, and execution.

This company has its finger in every pie—and Wall Street is just starting to notice.

Wall Street is noticing this company also because it is quietly riding all of these tailwinds—without the sky-high valuation.

While most energy and utility firms are buried under mountains of debt and coughing up hefty interest payments just to appease bondholders…

This company is completely debt-free.

In fact, it’s sitting on a war chest of cash—equal to nearly one-third of its entire market cap.

It also owns a huge equity stake in another red-hot AI play, giving investors indirect exposure to multiple AI growth engines without paying a premium.

And here’s what the smart money has started whispering…

The Hedge Fund Secret That’s Starting to Leak Out

This stock is so off-the-radar, so absurdly undervalued, that some of the most secretive hedge fund managers in the world have begun pitching it at closed-door investment summits.

They’re sharing it quietly, away from the cameras, to rooms full of ultra-wealthy clients.

Why? Because excluding cash and investments, this company is trading at less than 7 times earnings.

And that’s for a business tied to:

  • The AI infrastructure supercycle
  • The onshoring boom driven by Trump-era tariffs
  • A surge in U.S. LNG exports
  • And a unique footprint in nuclear energy—the future of clean, reliable power

You simply won’t find another AI and energy stock this cheap… with this much upside.

This isn’t a hype stock. It’s not riding on hope.

It’s delivering real cash flows, owns critical infrastructure, and holds stakes in other major growth stories.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 100+% Return within 12 to 24 months.

We’re now offering month-to-month subscriptions with no commitments.

For a ridiculously low price of just $9.99 per month, you can unlock our in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!